Trials / Unknown
UnknownNCT01448746
Optimal Prophylactic Method of Venous Thromboembolism (VTE)
Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 682 (actual)
- Sponsor
- The Catholic University of Korea · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is to define the optimal method of prophylaxis for patients with gastrectomy in Korea and the investigators hypothesized only mechanical method would be enough for preventing VTE on perioperative period.
Detailed description
Venous thromboembolism (VTE) is common and often fatal complication in patients with cancer. Gastric cancer is the most frequent cancer in Korea. The incidence of VTE would be increased in patients with gastric cancer, especially associated surgery. However, the incidence and optimal prophylactic method associated with cancer surgery are not well studied in Asian patients. Most Korean surgeon concerns regarding the increased postoperative bleeding associated with low molecular weight heparin(LMWH)prophylaxis. The incidence and adverse event will be examined to define the optimal prophylactic method of VTE in surgical patients with gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | low molecular weight heparin | 40mg 12 hours before surgery and 12 hours later surgery |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2016-01-01
- Completion
- 2017-08-01
- First posted
- 2011-10-07
- Last updated
- 2017-02-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01448746. Inclusion in this directory is not an endorsement.